Hanall Biopharma Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hanall Biopharma Company Limited with three other
companies in this sector in South Korea:
Binex Company Ltd
sales of 81.36 billion Korean Won [US$72.25 million]
of which 73%
Dongsung Pharmaceutical Company Limited
(79.72 billion Korean Won [US$70.79 million]
of which 89%
was Pharmaceutical Segment), and
JW Shinyak Corp
(83.38 billion Korean Won [US$74.05 million]
Hanall Biopharma Company Limited reported sales of 82.88 billion Korean Won (US$73.60 million)
December of 2016.
increase of 3.6%
versus 2015, when the company's sales were 80.02 billion Korean Won.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Hanall Biopharma Company Limited had sales
of 87.70 billion Korean Won.